Remdesivir: Effectiveness and Safety in Hospitalized Patients with COVID-19 (ReEs-COVID-19)—Analysis of Data from Daily Practice

Remdesivir was the first antiviral approved for treating COVID-19. We investigated its patterns of use, effectiveness and safety in clinical practice in Greece. This is a retrospective observational study of hospitalized adults who received remdesivir for COVID-19 in September 2020–February 2021. Th...

Olles dieđut

Bibliográfalaš dieđut

Váldodahkkit:	Nikos Pantazis, Evmorfia Pechlivanidou, Anastasia Antoniadou, Karolina Akinosoglou, Ioannis Kalomenidis, Garyfallia Poulakou, Haralampos Milionis, Periklis Panagopoulos, Markos Marangos, Ioannis Katsarolis, Pinelopi Kazakou, Vasiliki Dimakopoulou, Anna-Louiza Chaliasou, Vasiliki Rapti, Eirini Christaki, Angelos Liontos, Vasileios Petrakis, Georgios Schinas, Dimitrios Biros, Maria-Christina Rimpa, Giota Touloumi
Materiálatiipa:	Artigo
Giella:	Inglês
Almmustuhtton:	MDPI AG 2023-08-01
Ráidu:	Microorganisms
Fáttát:	COVID-19 remdesivir hospitalized patients effectiveness safety
Liŋkkat:	https://www.mdpi.com/2076-2607/11/8/1998
Fáddágilkorat:	Lasit fáddágilkoriid Eai fáddágilkorat, Lasit vuosttaš fáddágilkora!